Edition:
India

Meilleure Health International Industry Group Ltd (2327.HK)

2327.HK on Hong Kong Stock

0.77HKD
1:29pm IST
Change (% chg)

HK$-0.01 (-1.28%)
Prev Close
HK$0.78
Open
HK$0.77
Day's High
HK$0.84
Day's Low
HK$0.76
Volume
15,696,000
Avg. Vol
42,859,599
52-wk High
HK$1.64
52-wk Low
HK$0.33

Summary

Name Age Since Current Position

Xuzhou Zhou

58 2013 Executive Chairman of the Board

Wen Chuan Zhou

31 2013 Chief Executive Officer, Executive Director

Man Fai Shek

39 2014 Finance Controller, Company Secretary

Lailin Liu

58 2013 Executive Director

Zhenhua Mao

51 2015 Non-Executive Director

Chi Wai Chau

51 2013 Independent Non-Executive Director

Guanjiang Gao

65 2013 Independent Non-Executive Director

Wentao Zeng

54 2017 Non-Executive Independent Director

Biographies

Name Description

Xuzhou Zhou

Mr. Zhou Xuzhou is Executive Chairman of the Board of Jiwa Bio-Pharm Holdings Ltd. He was appointed as an executive director of the Company on 30 August 2013 and was appointed as the Chairman of the Company on 23 September 2013. He is the Chairman of the Nomination Committee of the Company. Mr. Zhou obtained a Master of Arts in Library Studies from the University of Wuhan in 1985. He is the founder and chairman of the board of directors, chief executive officer and the sole shareholder of (U-Home Group Limited*). U-Home Group Limited is a company incorporated under the laws of the PRC and, together with over twenty of its subsidiaries, is principally engaged in real estate development, hotel management and property management in various cities in the PRC. Mr. Zhou, through subsidiaries wholly owned by him, has started his real estate business since 1992. Mr. Zhou is primarily responsible for leading the strategic planning and business development of U-Home Group Holdings Limited and overseeing all key aspects of the operations of U-Home Group Holdings Limited, including financial management and project development business. He has over 21 years of experience in the property industry.

Wen Chuan Zhou

Ms. Zhou Wen Chuan is Chief Executive Officer and Executive Director of Jiwa Bio-Pharm Holdings Limited. She has been Executive Director. since 30 August 2013 and was appointed as a Chief Executive Officer on 23 September 2013. Ms. Zhou obtained a master degree in Business Administration from the Chinese University of Hong Kong in 2011, and a master degree in Food Science and a bachelor degree in Science in Food Nutrition and Health from the University of British Columbia in 2008 and 2007 respectively.

Man Fai Shek

Mr. Shek Man Fai is Finance Controller, Company Secretary of Jiwa Bio-Pharm Holdings Ltd. since April 26, 2013. He is the Senior Finance Manager of the Company. He joined the Company in November 2006. Mr. Shek has over 19 years of experience in financial accounting. He is a member of the Association of Chartered Certified Accountants and a fellow member of the Hong Kong Institute of Certified Public Accountants. Mr. Shek holds a Bachelor Degree in Business Accounting from the University of Lincolnshire and Humberside and a Master Degree in Finance from the National University of Ireland.

Lailin Liu

Mr. Liu Lailin is Executive Director of Jiwa Bio-Pharm Holdings Limited. since 30 August 2013. He is the member of the Nomination Committee of the Company. Mr. Liu joined (Anhui Yuhua Enterprises Company Ltd.*), the immediate holding company of U-Home Group Limited, in 1994. He is currently a director and executive vice president of U-Home Group Limited and the chairman of (Chuzhou Yuda Property Development Company Ltd.*), a subsidiary of U-Home Group Limited. Prior to joining Anhui Yuhua Enterprises Company Ltd., Mr. Liu was the assistant accountant of (Datang Xiangtan Power Generation Co., Ltd.*). Mr. Liu has over 17 years of experience in real estate management. He obtained a Diploma of Management of Industrial Enterprise from Hunan Radio and Television University in 1986.

Zhenhua Mao

Mr. Mao Zhenhua is Non-Executive Director of the Company. He is currently the Chairman and Chief Executive Officer of China Chengxin Credit Management Co., Ltd. , Professor of Renmin University of China and Chairman of the Institute of Economy. Mr. Mao graduated from Wuhan University with a doctorate in Economics. Mr. Mao had carried out economic analysis and policies research for Hubei Provincial Government, Hainan Provincial Government and Research Office of the State Council. Mr. Mao founded China Chengxin Company (“China Chengxin”) in 1992. He acted as its General Manager, Chairman and General Manager, Chief Executive Officer. He was the Deputy Chairman and Chief Executive Officer of China Cheng Xin International Credit Rating Co. Ltd.. Under the leadership of Mr. Mao, China Chengxin has become a company specialising in credit services and a comprehensive enterprise group principally engaging in the business of investing in banks, real estates and industries.

Chi Wai Chau

Professor Chi Wai (Wilton) Chau is Independent Non-Executive Director of Jiwa Bio-Pharm Holdings Limited. He was appointed as an independent non-executive director of the Company on 30 August 2013. He is a member of the Remuneration Committee and a member of the Nomination Committee of the Company. Professor Chau obtained a doctoral degree in business administration, a master degree in business administration, a bachelor degree in laws and a bachelor degree in science. He is a fellow member of the Chartered Association of Certified Accountants (UK). Prof. Chau currently serves on the boards and committees of non-profit making organisations, including Hong Kong Biotechnology Organisation and Hong Kong Business Angel Network Limited. He is currently an independent non-executive director of Angang Steel Company Limited (H-Share Stock Code: 347; A-Share Stock Code: 898). He was an independent non-executive director of Guangshen Railway Company Limited (H-Share Stock Code: 525; A-Share Stock Code: 601333) from 2004 to 2011. He is also a Professor of Practice in Entrepreneurship in the Chinese University of Hong Kong. Prof. Chau has over 27 years of experience in direct investment and venture capital.

Guanjiang Gao

Mr. Gao Guanjiang is Independent Non-Executive Director of Jiwa Bio-Pharm Holdings Limited. since August 30, 2013. He was appointed as an independent non-executive director of the Company on 30 August 2013. He is the Chairman of the Remuneration Committee and a member of the Audit Committee of the Company. Mr. Gao graduated from the Wuhan University with a Ph. D in Economics. Mr. Gao is currently an executive director of Cinda International Holdings Limited (Stock Code: 111). Mr. Gao has over 20 years of experience in commercial banking, investment banking, business administration and securities and finance.

Wentao Zeng

Mr. Zeng Wentao is Non-Executive Independent Director of the Company. He graduated from Wuhan University with a doctorate degree in Economics. Mr. Zeng founded Hainan Sanyou Real Estate Company Limited at Hainan in 1990 and acted as its general manager. In 1995, he founded Wuhan Yinhai Property Company Limited, which was principally engaged in real estate development and technology investment, and acted as its chief executive officer. He is the chief executive officer of Zhongjia Capital (Wuhan) Investment Management Company Limited since March 2017. He is a part-time professor of Zhongnan University of Economics and Law and Central China Normal University, a member of Zhongnan University of Economics and Law Education Foundation and standing council member of Dong Furen Foundation. He was the vice-chairman of 12th and 13th Federation of Industry and Commerce of Wuhan City and a member of the 11th and 12th People’s Consultative Conference of Wuhan City.

Basic Compensation

Name Fiscal Year Total

Xuzhou Zhou

292,000

Wen Chuan Zhou

175,000

Man Fai Shek

--

Lailin Liu

175,000

Zhenhua Mao

--

Chi Wai Chau

70,000

Guanjiang Gao

70,000

Wentao Zeng

--
As Of  31 Mar 2014